To include your compound in the COVID-19 Resource Center, submit it here.

Abraxane nab-paclitaxel: Final Phase III data

Final data from the open-label, international Phase III Study CA031 trial in 1,052 patients showed that first-line Abraxane plus carboplatin led to a median PFS and OS of

Read the full 285 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE